ストックスクリーナーアプリを入手
0.7928
0.88%
0.0069
前日終値:
$0.7859
開ける：
$0.78
24時間の取引高:
151.54K
Relative Volume:
1.08
時価総額：
$15.51M
収益：
$411.00K
当期純損益:
$-4.85M
株価収益率:
-1.8018
EPS:
-0.44
ネットキャッシュフロー:
$-4.88M
1週間 パフォーマンス:
-3.26%
1か月 パフォーマンス:
-18.27%
6か月 パフォーマンス:
-45.32%
1年 パフォーマンス:
-73.83%
1日の値動き範囲:
$0.7749
$0.82
1週間の範囲:
$0.7749
$0.877
52週間の値動き範囲:
$0.7749
$4.38
Lexaria Bioscience Corp Stock (LEXX) Company Profile
名前
Lexaria Bioscience Corp
セクター
電話
250-765-6424
住所
100 - 740 MCCURDY ROAD, KELOWNA
LEXX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.7928 | 16.36M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp (LEXX) 最新ニュース
Will Lexaria Bioscience Corp. Equity Warrant benefit from macro trends2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
Chartists See Breakout Potential in Lexaria Bioscience Corp.Weekly Profit Report & Community Verified Watchlist Alerts - newsyoung.net
Pattern recognition hints at Lexaria Bioscience Corp. upsideJuly 2025 Trends & Consistent Profit Trade Alerts - Newser
How to build a custom watchlist for Lexaria Bioscience Corp.July 2025 Gainers & Weekly Return Optimization Alerts - Newser
Will Lexaria Bioscience Corp. benefit from macro trendsMarket Risk Summary & Technical Buy Zone Confirmations - Newser
Technical signs of recovery in Lexaria Bioscience Corp.Quarterly Performance Summary & Reliable Price Breakout Signals - Newser
Price action breakdown for Lexaria Bioscience Corp.2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Has Lexaria Bioscience Corp. Equity Warrant formed a bullish divergenceRate Hike & Free Community Supported Trade Ideas - Newser
Using Bollinger Bands to evaluate Lexaria Bioscience Corp.Buy Signal & Safe Capital Growth Plans - Newser
Will Lexaria Bioscience Corp. price bounce be sustainableDay Trade & Capital Efficiency Focused Strategies - Newser
What recovery options are there for Lexaria Bioscience Corp.Market Performance Summary & Community Consensus Picks - Newser
What earnings revisions data tells us about Lexaria Bioscience Corp. Equity Warrant2025 Short Interest & Growth Focused Entry Point Reports - Newser
Regression analysis insights on Lexaria Bioscience Corp. Equity Warrant performanceJuly 2025 Volume & AI Optimized Trade Strategies - Newser
Can Lexaria Bioscience Corp. rally from current levels2025 Trading Volume Trends & AI Driven Stock Reports - Newser
Price momentum metrics for Lexaria Bioscience Corp. Equity Warrant explainedTrade Ideas & Verified Chart Pattern Trade Signals - Newser
Lexaria Bioscience Corp. Equity Warrant stock volume spike explained2025 Momentum Check & Weekly Chart Analysis and Guides - Newser
Comparing Lexaria Bioscience Corp. in custom built stock radarsJuly 2025 Macro Moves & Community Supported Trade Ideas - Newser
What’s the recovery path for long term holders of Lexaria Bioscience Corp. Equity WarrantEarnings Overview Summary & Risk Managed Trade Strategies - Newser
Heatmap analysis for Lexaria Bioscience Corp. and competitorsMarket Movement Recap & Daily Chart Pattern Signal Reports - Newser
Risk adjusted return profile for Lexaria Bioscience Corp. analyzedPortfolio Return Report & Growth-Oriented Investment Plans - Newser
Multi factor analysis applied to Lexaria Bioscience Corp. Equity WarrantWeekly Stock Summary & Weekly Market Pulse Alerts - Newser
Lexaria Bioscience Corp. Equity Warrant recovery potential after sell offEarnings Beat & Low Risk Entry Point Guides - Newser
Will Lexaria Bioscience Corp. Equity Warrant bounce back from current support2025 Key Lessons & Free Verified High Yield Trade Plans - Newser
Is Lexaria Bioscience Corp. Equity Warrant showing signs of accumulation2025 Market Outlook & Fast Exit and Entry Strategy Plans - Newser
Forecasting Lexaria Bioscience Corp. price range with options data2025 Volatility Report & Weekly High Momentum Picks - Newser
Will Lexaria Bioscience Corp. continue its uptrend2025 Market Overview & Precise Buy Zone Tips - Newser
What MACD and RSI say about Lexaria Bioscience Corp.2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
Is it too late to sell Lexaria Bioscience Corp. Equity WarrantJuly 2025 Catalysts & Verified Momentum Stock Ideas - Newser
Lexaria Bioscience Completes Key Phase 1b Study Milestone - MSN
What to expect from Lexaria Bioscience Corp. Equity Warrant in the next 30 daysRisk Management & Expert Approved Momentum Trade Ideas - Newser
Will earnings trigger a reversal in Lexaria Bioscience Corp. Equity WarrantTrade Volume Report & Smart Allocation Stock Reports - Newser
Chart based analysis of Lexaria Bioscience Corp. Equity Warrant trendsMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
What Fibonacci levels say about Lexaria Bioscience Corp. reboundWeekly Market Report & AI Optimized Trade Strategies - Newser
Using data models to predict Lexaria Bioscience Corp. stock movementJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Can Lexaria Bioscience Corp. be recession proof2025 Support & Resistance & Reliable Volume Spike Alerts - mustnews.co.kr
Why Lexaria Bioscience Corp. Equity Warrant stock attracts strong analyst attentionWeekly Loss Report & Verified Momentum Stock Ideas - Newser
How Lexaria Bioscience Corp. stock performs during market volatility2025 Market Outlook & Advanced Technical Signal Analysis - newsimpact.co.kr
How to read the order book for Lexaria Bioscience Corp.Weekly Investment Report & Verified Entry Point Signals - Newser
Lexaria Bioscience's DehydraTECH Platform: A Disruptive Force in GLP-1 Oral Delivery - AInvest
Lexaria Bioscience Completes Last Patient, Last Visit in Phase 1b GLP-1 Study, Awaits Laboratory Analysis - AInvest
Lexaria Bioscience announces last patient, last visit in Phase 1b GLP-1 study - Yahoo Finance
What MACD and RSI say about Lexaria Bioscience Corp. Equity WarrantGlobal Markets & AI Enhanced Trading Alerts - Newser
Lexaria Bioscience Corp. Equity Warrant Stock Support and Resistance Levels You Should KnowJuly 2025 Outlook & Technical Pattern Alert System - Newser
Risk vs reward if holding onto Lexaria Bioscience Corp.Earnings Miss & Stock Portfolio Risk Management - Newser
Lexaria Bioscience Corp (LEXX) 財務データ
収益
当期純利益
現金流量
EPS
Lexaria Bioscience Corp (LEXX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | Director |
Jul 30 '25 |
Buy |
0.91 |
11,900 |
10,866 |
281,912 |
| McKechnie William Edward | Director |
Jul 29 '25 |
Buy |
0.91 |
5,000 |
4,532 |
18,191 |
| DOCHERTY JOHN MARTIN | President & CSO |
Jul 29 '25 |
Buy |
0.93 |
5,376 |
4,989 |
5,376 |
| Carle Vanessa | Secretary |
Jul 29 '25 |
Buy |
0.91 |
750 |
682 |
750 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Jul 29 '25 |
Buy |
0.91 |
15,000 |
13,641 |
65,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 03 '24 |
Buy |
2.47 |
27,172 |
67,175 |
50,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 02 '24 |
Buy |
2.24 |
22,828 |
51,217 |
22,828 |
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):